Ardelyx (ARDX) Non-Current Deffered Revenue (2013 - 2026)

Ardelyx (ARDX) posted Non-Current Deffered Revenue of $13.7 million for Q1 2026, little changed on a QoQ basis from $13.7 million in Q4 2025, and up 64.06% year-over-year from $8.4 million in Q1 2025.

Ardelyx (ARDX) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Ardelyx's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $13.7 million for Q1 2026.

  • Quarterly Non-Current Deffered Revenue rose 64.06% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 64.06% YoY) and the FY2025 annual result came in at $13.7 million, up 89.42% from the prior year.
  • Non-Current Deffered Revenue was $13.7 million for Q1 2026 at Ardelyx, roughly flat from $13.7 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $13.7 million in Q3 2025 and bottomed at $7.2 million in Q4 2024.
  • A 5-year average of $10.7 million and a median of $10.3 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 321.48% — and 2025, when it plunged 31.01%.
  • Ardelyx's Non-Current Deffered Revenue stood at $9.0 million in 2022, then retreated by 4.22% to $8.6 million in 2023, then fell by 16.34% to $7.2 million in 2024, then surged by 89.42% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
  • Business Quant data shows ARDX's Non-Current Deffered Revenue at $13.7 million in Q1 2026, $13.7 million in Q4 2025, and $13.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 13.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.70 Mn
Dec 31, 2025 13.70 Mn
Sep 30, 2025 13.70 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 7.23 Mn
Sep 30, 2024 12.77 Mn
Jun 30, 2024 9.61 Mn
Mar 31, 2024 12.10 Mn
Dec 31, 2023 8.64 Mn
Sep 30, 2023 10.29 Mn
Jun 30, 2023 9.24 Mn
Mar 31, 2023 11.50 Mn
Dec 31, 2022 9.03 Mn
Sep 30, 2022 8.56 Mn
Jun 30, 2022 12.42 Mn
Mar 31, 2022 8.56 Mn
Dec 31, 2021 4.73 Mn
Sep 30, 2021 2.95 Mn
Jun 30, 2021 2.95 Mn